Bevacizumab as adjuvant therapy in the management of pterygium: a systematic review and Meta-analysis
AIM: To evaluate the clinical effect of bevacizumab in pterygium treatment. METHODS: A systematic review and quantitative Meta-analysis was performed. PubMed, EMBASE, Web of Science and Cochrane database were searched for eligible literatures published in English until June 2016. The endpoint was r...
Main Authors: | Jian Liu, Jie-Hui Xu, Wen Xu, Guan-Lu Liang, Ji-Xian Lou, Yi Wang, Ji-Quan Wen, Yong-Bao Cao |
---|---|
Format: | Article |
Language: | English |
Published: |
Press of International Journal of Ophthalmology (IJO PRESS)
2017-07-01
|
Series: | International Journal of Ophthalmology |
Subjects: | |
Online Access: | http://www.ijo.cn/en_publish/2017/7/20170717.pdf |
Similar Items
-
Subconjunctival Bevacizumab for Primary Pterygium Excision; a Randomized Clinical Trial
by: Mohammad-Reza Razeghinejad, et al.
Published: (2014-01-01) -
Anti-fibrotic, anti-VEGF or radiotherapy treatments as adjuvants for pterygium excision: a systematic review and network meta-analysis
by: Wen Zeng, et al.
Published: (2017-11-01) -
Subconjunctival bevacizumab injection versus mitomycin C application after primary pterygium surgery
by: Hani A Albialy, et al.
Published: (2019-01-01) -
Does topical bevacizumab prevent postoperative recurrence after pterygium surgery with conjunctival autografting?
by: Aylin Karalezli, et al.
Published: (2014-06-01) -
Subconjunctival Bevacizumab Injection in Treatment of Pterygium
by: Mohammad Reza Besharati, et al.
Published: (2011-03-01)